[go: up one dir, main page]

EE200100453A - Betahistiini reguleeritult vabastav preparaat - Google Patents

Betahistiini reguleeritult vabastav preparaat

Info

Publication number
EE200100453A
EE200100453A EEP200100453A EEP200100453A EE200100453A EE 200100453 A EE200100453 A EE 200100453A EE P200100453 A EEP200100453 A EE P200100453A EE P200100453 A EEP200100453 A EE P200100453A EE 200100453 A EE200100453 A EE 200100453A
Authority
EE
Estonia
Prior art keywords
betahistine
controlled release
release preparation
preparation
controlled
Prior art date
Application number
EEP200100453A
Other languages
English (en)
Inventor
Fabiani Flavio
Frimonti Enrico
Valenti Mauro
Original Assignee
Farmaceutici Formenti S.P.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Farmaceutici Formenti S.P.A. filed Critical Farmaceutici Formenti S.P.A.
Publication of EE200100453A publication Critical patent/EE200100453A/et

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4402—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 2, e.g. pheniramine, bisacodyl
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Cardiology (AREA)
  • Otolaryngology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
EEP200100453A 1999-03-05 2000-02-28 Betahistiini reguleeritult vabastav preparaat EE200100453A (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT1999MI000454A IT1309591B1 (it) 1999-03-05 1999-03-05 Composizioni a rilascio controllato di betaistina.
PCT/EP2000/001642 WO2000053162A1 (en) 1999-03-05 2000-02-28 Controlled-release compositions of betahistine

Publications (1)

Publication Number Publication Date
EE200100453A true EE200100453A (et) 2002-12-16

Family

ID=11382165

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200100453A EE200100453A (et) 1999-03-05 2000-02-28 Betahistiini reguleeritult vabastav preparaat

Country Status (37)

Country Link
EP (1) EP1158963B1 (et)
JP (1) JP2002538197A (et)
KR (1) KR20010102498A (et)
CN (1) CN1165295C (et)
AR (1) AR029154A1 (et)
AT (1) ATE231392T1 (et)
AU (1) AU762532B2 (et)
BG (1) BG105807A (et)
BR (1) BR0008739A (et)
CA (1) CA2364226A1 (et)
CO (1) CO5170438A1 (et)
CZ (1) CZ299510B6 (et)
DE (1) DE60001266T2 (et)
DK (1) DK1158963T3 (et)
EE (1) EE200100453A (et)
ES (1) ES2189739T3 (et)
GE (1) GEP20033078B (et)
HK (1) HK1042246B (et)
HR (1) HRP20010650A2 (et)
HU (1) HUP0200243A2 (et)
ID (1) ID30127A (et)
IL (1) IL145263A0 (et)
IT (1) IT1309591B1 (et)
MX (1) MXPA01008893A (et)
NO (1) NO319135B1 (et)
NZ (1) NZ513949A (et)
PE (1) PE20001547A1 (et)
PL (1) PL196290B1 (et)
PT (1) PT1158963E (et)
RU (1) RU2248791C2 (et)
SI (1) SI1158963T1 (et)
SK (1) SK284584B6 (et)
TR (1) TR200102566T2 (et)
UA (1) UA65652C2 (et)
WO (1) WO2000053162A1 (et)
YU (1) YU64001A (et)
ZA (1) ZA200107318B (et)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100712356B1 (ko) * 2003-01-23 2007-05-02 (주)아모레퍼시픽 서방성 제제 및 그의 제조방법
ES2306827T3 (es) * 2003-07-04 2008-11-16 Farmaceutici Formenti S.P.A. Composiciones de betahistina de liberacion controlada.
BRPI0506807A (pt) 2004-04-22 2007-05-29 Mor Research Applic Ltd método de gerenciamento de consumo de alimento e composição farmacológica
US7728015B2 (en) 2004-04-22 2010-06-01 Mor Research Applications Ltd. Compositions for weight management
WO2006009403A1 (en) * 2004-07-22 2006-01-26 Amorepacific Corporation Sustained-release preparations containing topiramate and the producing method thereof
JP2006176461A (ja) * 2004-12-24 2006-07-06 Dai Ichi Seiyaku Co Ltd 粒状物
EP2293794B1 (en) 2008-05-27 2013-05-22 The University of Melbourne Methods of treating mammals with eustachian tube dysfunctions
EP2314296A1 (en) * 2009-10-22 2011-04-27 Abdi Ibrahim Ilac Sanayi Ve Ticaret Anonim Sirketi Orally Disintegrating Tablets of Betahistine
EP2491930A1 (en) * 2011-02-25 2012-08-29 Deva Holding Anonim Sirketi Pharmaceutical combination of betahistine and trimetazidine
DE102012105528A1 (de) 2012-06-25 2014-01-02 Hennig Arzneimittel Gmbh & Co. Kg Arzneiform zur Freisetzung von Wirkstoffen
WO2015053620A1 (en) * 2013-10-07 2015-04-16 Disphar International B.V. Betahistine composition
EP3431078B1 (en) * 2017-07-20 2021-01-20 Intas Pharmaceuticals Limited Non-pulsatile prolonged-release betahistine oral solid compositions

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2397840B1 (et) * 1977-07-22 1981-03-20 Cherqui Jean
FR2432313A1 (fr) * 1978-08-01 1980-02-29 Foulhoux Pierre Nouvelle forme galenique de la betahistine et son procede d'obtention
GB2280604B (en) * 1993-07-02 1997-04-30 Resource Medical Limited Processing of active agents
JP2002511777A (ja) * 1996-10-28 2002-04-16 ゼネラル ミルズ，インコーポレイテッド 調放性粒子の埋包およびカプセル化

Also Published As

Publication number Publication date
IL145263A0 (en) 2002-06-30
DE60001266D1 (de) 2003-02-27
PL350232A1 (en) 2002-11-18
ZA200107318B (en) 2002-09-04
NO319135B1 (no) 2005-06-20
HK1042246A1 (en) 2002-08-09
ID30127A (id) 2001-11-08
JP2002538197A (ja) 2002-11-12
GEP20033078B (en) 2003-10-27
NZ513949A (en) 2003-10-31
YU64001A (sh) 2004-05-12
AU762532B2 (en) 2003-06-26
CO5170438A1 (es) 2002-06-27
PL196290B1 (pl) 2007-12-31
CZ299510B6 (cs) 2008-08-20
DE60001266T2 (de) 2003-08-28
CA2364226A1 (en) 2000-09-14
DK1158963T3 (da) 2003-04-28
CN1165295C (zh) 2004-09-08
SK284584B6 (sk) 2005-07-01
PE20001547A1 (es) 2001-01-29
EP1158963B1 (en) 2003-01-22
NO20014301L (no) 2001-09-04
BG105807A (bg) 2002-03-29
ATE231392T1 (de) 2003-02-15
PT1158963E (pt) 2003-06-30
CZ20013186A3 (cs) 2002-02-13
UA65652C2 (uk) 2004-04-15
ES2189739T3 (es) 2003-07-16
RU2248791C2 (ru) 2005-03-27
TR200102566T2 (tr) 2002-01-21
MXPA01008893A (es) 2002-10-23
KR20010102498A (ko) 2001-11-15
EP1158963A1 (en) 2001-12-05
ITMI990454A1 (it) 2000-09-05
SI1158963T1 (en) 2003-04-30
SK12492001A3 (sk) 2001-12-03
NO20014301D0 (no) 2001-09-04
IT1309591B1 (it) 2002-01-24
HK1042246B (zh) 2005-06-03
CN1342069A (zh) 2002-03-27
HUP0200243A2 (en) 2002-06-29
AR029154A1 (es) 2003-06-18
BR0008739A (pt) 2001-12-26
AU3283100A (en) 2000-09-28
WO2000053162A1 (en) 2000-09-14
HRP20010650A2 (en) 2002-10-31

Similar Documents

Publication Publication Date Title
PT1210113E (pt) Composicoes de vacinas de combinacao
DK1140105T3 (da) Galantaminpræparat med styret frigivelse
AR027907A1 (es) Composicion de liberacion controlada
AR026045A1 (es) Formulaciones de liberacion prolongada de derivados de eritromocina
NO20021540D0 (no) Sammensetninger med kontrollert frigivelse omfattende nimesulfid
NO20054715L (no) Fremgangsmater og mellomprodukter for fremstilling av anti-cancer forbindelser
EP1311350A4 (en) TAXED SUBSTANCE DISCOUNT
DK1326585T3 (da) Fremgangsmåde til fremstilling af pulverformuleringer
DK1147083T3 (da) Arylpiperazinyl-cyclohexylindolderivater til behandling af depression
DK1173431T3 (da) Fremgangsmåde til fremstilling af citalopram
PT1162973E (pt) Preparacao de cilostazole
DK1105382T3 (da) Fremgangsmåde til fremstilling af citalopram
DK1159274T3 (da) Fremgangsmåde til fremstilling af citalopram
PT1150966E (pt) Metodo de preparacao de 5-cianoftalido
DK1218096T3 (da) Mikrokapsler med variabel frisætning
EE200100453A (et) Betahistiini reguleeritult vabastav preparaat
EP1225971A4 (en) CONTROLLED RELEASE OF SUBSTANCES
NO20016151D0 (no) Fremstilling av substituerte piperidin-4-oner
DK1187833T3 (da) Fremgangsmåde til fremstilling af thiamethoxam
NO20025423D0 (no) FremgangsmÕte for fremstilling av Citalopram
NO20030515D0 (no) Fremgangsmåte for fremstilling av dinapsolin
DK1228056T3 (da) Fremgangsmåde til fremstilling af citalopram
DK1203000T3 (da) Fremgangsmåde til fremstilling af phosphonomethylglycin
ITMI992048A0 (it) Procedimento stereoselettivo per la preparazione di endo-3-amminoazabi cicloalcani
DK1177165T3 (da) Fremgangsmåde til fremstilling af pesticidmellemprodukter